ARCHIVES

Clinical Trial Pathology Improvements Recommended By Group Remaining Actions After Merit Review

This article is from The Cancer Letter archive.

Vol. 05 No. 02 | January 12, 1979

Download PDF Visit The Full Archive

Related Articles

Stop Cancer Promises $7 Mil. By End Of Year

October 12, 1990

Clinton Endorses Legislation Preventing Genetic Discrimination

May 23, 1997

In Brief: HHS Drags Feet, NCI Considering Contract To Review Cancer Research Facility Needs

October 14, 1983

‘Rush To Downsize’ Is A Danger To NCI, Broder Warns In A Farewell Address

January 13, 1995

In Brief: Lawyers Halt Reference Chemical Distribution To Grantees, Threaten To Stop Viruses, Animals

September 2, 1977

NCI Plans $61 Million For Six-Year Program In Biomarker Research For Early Detection

December 4, 1998